Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$0.58 - $1.3 $1.58 Million - $3.53 Million
-2,717,012 Reduced 91.57%
250,000 $257,000
Q1 2023

May 15, 2023

BUY
$1.09 - $1.82 $1.93 Million - $3.22 Million
1,771,929 Added 148.27%
2,967,012 $4.04 Million
Q4 2022

Feb 14, 2023

BUY
$1.52 - $3.39 $717,859 - $1.6 Million
472,276 Added 65.34%
1,195,083 $1.83 Million
Q3 2022

Nov 14, 2022

BUY
$1.7 - $4.05 $1.2 Million - $2.86 Million
705,952 Added 4188.38%
722,807 $2.11 Million
Q2 2022

Aug 09, 2022

SELL
$1.6 - $5.07 $152,907 - $484,524
-95,567 Reduced 85.01%
16,855 $31,000
Q1 2022

May 13, 2022

BUY
$3.92 - $5.86 $32,144 - $48,052
8,200 Added 7.87%
112,422 $490,000
Q4 2021

Feb 09, 2022

BUY
$5.0 - $14.85 $175,840 - $522,244
35,168 Added 50.93%
104,222 $563,000
Q3 2021

Nov 15, 2021

BUY
$12.13 - $16.99 $837,625 - $1.17 Million
69,054 New
69,054 $948,000

Others Institutions Holding AMRS

About AMYRIS, INC.


  • Ticker AMRS
  • Exchange NASDAQ
  • Sector Basic Materials
  • Industry Specialty Chemicals
  • Shares Outstandng 324,860,000
  • Market Cap $3.25M
  • Description
  • Amyris, Inc., a synthetic biotechnology company, operates in the clean health and beauty, and flavors and fragrance markets in Europe, North America, Asia, and South America. The company manufactures and sells clean beauty, personal care, and health and wellness consumer products, as well as ingredients to the flavor and fragrance, nutrition, fo...
More about AMRS
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.